Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(20%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

20%

Ph phase_2

60%

Ph phase_3

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

3(60.0%)

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (60.0%)

Phase 31 (20.0%)

N/A1 (20.0%)

Trials by Status

completed360%

withdrawn120%

active_not_recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

completedphase_2

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

NCT03375788

active_not_recruitingphase_2

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

NCT05983471

completednot_applicable

Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study

NCT03976336

withdrawnphase_3

Vitamin C and Atrial Fibrillation After Cardiac Surgery

NCT01580683

completedphase_2

Betaine in Patients With Nonalcoholic Steatohepatitis

NCT00586911

Clinical Trials (5)

Showing 5 of 5 trials

NCT03375788Phase 2

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Completed

NCT05983471Phase 2

Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)

Active Not Recruiting

NCT03976336Not Applicable

Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study

Completed

NCT01580683Phase 3

Vitamin C and Atrial Fibrillation After Cardiac Surgery

Withdrawn

NCT00586911Phase 2

Betaine in Patients With Nonalcoholic Steatohepatitis

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5